Lacey, M., Hunsche, E., Buzinec, P., Drake, W., Nagao, M., & Régulier, E. (2013). Hospitalization Costs Related To Pulmonary Hypertension (Ph) Among Medicare Advantage Or Commercially Insured Patients With Pulmonary Arterial Hypertension (Pah) In The United States. Value in Health, 16(3), A233. https://doi.org/10.1016/j.jval.2013.03.1184
Chicago Style (17th ed.) CitationLacey, M., E. Hunsche, P. Buzinec, W. Drake, M. Nagao, and E. Régulier. "Hospitalization Costs Related To Pulmonary Hypertension (Ph) Among Medicare Advantage Or Commercially Insured Patients With Pulmonary Arterial Hypertension (Pah) In The United States." Value in Health 16, no. 3 (2013): A233. https://doi.org/10.1016/j.jval.2013.03.1184.
MLA (9th ed.) CitationLacey, M., et al. "Hospitalization Costs Related To Pulmonary Hypertension (Ph) Among Medicare Advantage Or Commercially Insured Patients With Pulmonary Arterial Hypertension (Pah) In The United States." Value in Health, vol. 16, no. 3, 2013, p. A233, https://doi.org/10.1016/j.jval.2013.03.1184.